Delphia (USA)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,176
Closed -$368K 108
2023
Q2
$368K Sell
4,176
-55
-1% -$4.74K 0.58% 55
2023
Q1
$341K Sell
4,231
-1,777
-30% -$145K 0.42% 94
2022
Q4
$467K Sell
6,008
-892
-13% -$72.3K 0.54% 56
2022
Q3
$557K Sell
6,900
-1,243
-15% -$112K 0.64% 30
2022
Q2
$731K Buy
8,143
+4,541
+126% +$460K 0.5% 48
2022
Q1
$400K Buy
3,602
+1,232
+52% +$130K 0.3% 115
2021
Q4
$245K Buy
+2,370
New +$274K 0.26% 165

Other funds holding MDT

Delphia (USA)'s MDT Position: Q3 2023 in Review

Delphia (USA) sold out of Medtronic (MDT) in Q3 2023, closing a stake of 4,176 shares — an estimated $368K sold.

Delphia (USA) first reported a position in MDT in Q4 2021 and held it in 7 quarters. The position peaked at $731K in Q2 2022. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Delphia (USA) reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Delphia (USA) sold 4,176 Medtronic shares in Q3 2023, an estimated $368K.
  • Delphia (USA) first reported a position in Medtronic in Q4 2021 and held it in 7 quarters.
  • Delphia (USA)'s Medtronic position peaked at $731K in Q2 2022.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Delphia (USA)'s 13F filing for Q3 2023, filed 15 Nov 2023.